TTNP logo

Titan Pharmaceuticals (TTNP) Current Liabilities

Annual Current Liabilities

$1.44 M
-$1.19 M-45.10%

December 31, 2023


Summary


Performance

TTNP Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTTNPbalance sheetmetrics:

Quarterly Current Liabilities

$371.00 K
+$15.00 K+4.21%

September 30, 2024


Summary


Performance

TTNP Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTTNPbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

TTNP Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-45.1%-74.3%
3 y3 years-65.8%-83.7%
5 y5 years-58.2%-90.1%

TTNP Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-45.9%at low-86.1%+4.2%
5 y5-year-65.8%at low-93.7%+4.2%
alltimeall time-93.3%at low-98.3%+4.2%

Titan Pharmaceuticals Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$371.00 K(+4.2%)
Jun 2024
-
$356.00 K(-36.3%)
Mar 2024
-
$559.00 K(-61.3%)
Dec 2023
$1.44 M(-45.1%)
$1.44 M(-22.6%)
Sep 2023
-
$1.87 M(+1.1%)
Jun 2023
-
$1.85 M(-24.6%)
Mar 2023
-
$2.45 M(-7.0%)
Dec 2022
$2.63 M(-1.5%)
$2.63 M(0.0%)
Sep 2022
-
$2.63 M(+4.2%)
Jun 2022
-
$2.52 M(+10.8%)
Mar 2022
-
$2.28 M(-14.6%)
Dec 2021
$2.67 M(-36.8%)
$2.67 M(+38.6%)
Sep 2021
-
$1.93 M(-23.5%)
Jun 2021
-
$2.52 M(-33.0%)
Mar 2021
-
$3.76 M(-11.1%)
Dec 2020
$4.22 M(+17.3%)
$4.22 M(-28.1%)
Sep 2020
-
$5.88 M(+21.0%)
Jun 2020
-
$4.86 M(+10.1%)
Mar 2020
-
$4.41 M(+22.5%)
Dec 2019
$3.60 M(+4.3%)
$3.60 M(+3.4%)
Sep 2019
-
$3.48 M(-19.8%)
Jun 2019
-
$4.34 M(-8.8%)
Mar 2019
-
$4.76 M(+37.9%)
Dec 2018
$3.45 M(-22.7%)
$3.45 M(+56.8%)
Sep 2018
-
$2.20 M(-7.8%)
Jun 2018
-
$2.39 M(-12.1%)
Mar 2018
-
$2.72 M(-39.1%)
Dec 2017
$4.46 M(-8.1%)
$4.46 M(+126.4%)
Sep 2017
-
$1.97 M(+5.5%)
Jun 2017
-
$1.87 M(-17.7%)
Mar 2017
-
$2.27 M(-53.3%)
Dec 2016
$4.86 M(+0.1%)
$4.86 M(-27.7%)
Sep 2016
-
$6.72 M(+10.7%)
Jun 2016
-
$6.07 M(+19.4%)
Mar 2016
-
$5.08 M(+4.7%)
Dec 2015
$4.85 M(-27.2%)
$4.85 M(+5.6%)
Sep 2015
-
$4.59 M(-13.1%)
Jun 2015
-
$5.29 M(-1.0%)
Mar 2015
-
$5.34 M(-19.8%)
Dec 2014
$6.66 M(-38.6%)
$6.66 M(-10.7%)
Sep 2014
-
$7.46 M(-4.6%)
Jun 2014
-
$7.82 M(-14.6%)
Mar 2014
-
$9.16 M(-15.5%)
Dec 2013
$10.85 M(-49.3%)
$10.85 M(-11.5%)
Sep 2013
-
$12.25 M(-9.4%)
Jun 2013
-
$13.53 M(-32.3%)
Mar 2013
-
$19.98 M(-6.6%)
Dec 2012
$21.39 M(+317.6%)
$21.39 M(+96.4%)
Sep 2012
-
$10.89 M(+15.1%)
Jun 2012
-
$9.46 M(+60.8%)
Mar 2012
-
$5.89 M(+14.9%)
Dec 2011
$5.12 M(-5.2%)
$5.12 M(-19.7%)
Sep 2011
-
$6.38 M(+2.8%)
Jun 2011
-
$6.21 M(-28.8%)
Mar 2011
-
$8.71 M(+61.2%)
Dec 2010
$5.41 M
$5.41 M(+17.9%)
DateAnnualQuarterly
Sep 2010
-
$4.59 M(+91.7%)
Jun 2010
-
$2.39 M(-58.1%)
Mar 2010
-
$5.71 M(+268.9%)
Dec 2009
$1.55 M(-63.7%)
$1.55 M(-65.1%)
Sep 2008
-
$4.44 M(-8.1%)
Jun 2008
-
$4.83 M(+9.8%)
Mar 2008
-
$4.40 M(+3.4%)
Dec 2007
$4.26 M(+25.4%)
$4.26 M(+47.6%)
Sep 2007
-
$2.88 M(-11.2%)
Jun 2007
-
$3.25 M(-1.7%)
Mar 2007
-
$3.30 M(-2.7%)
Dec 2006
$3.39 M(+8.2%)
$3.39 M(-18.0%)
Sep 2006
-
$4.14 M(+38.0%)
Jun 2006
-
$3.00 M(-6.7%)
Mar 2006
-
$3.21 M(+2.5%)
Dec 2005
$3.14 M(-14.6%)
$3.14 M(-30.1%)
Sep 2005
-
$4.49 M(+30.9%)
Jun 2005
-
$3.43 M(-23.2%)
Mar 2005
-
$4.47 M(+21.7%)
Dec 2004
$3.67 M(+9.9%)
$3.67 M(+10.5%)
Sep 2004
-
$3.32 M(+26.2%)
Jun 2004
-
$2.63 M(-36.9%)
Mar 2004
-
$4.17 M(+24.9%)
Dec 2003
$3.34 M(-15.3%)
$3.34 M(-11.7%)
Sep 2003
-
$3.79 M(-5.2%)
Jun 2003
-
$3.99 M(+1.4%)
Mar 2003
-
$3.94 M(-0.3%)
Dec 2002
$3.94 M(-31.6%)
$3.94 M(+15.4%)
Sep 2002
-
$3.42 M(-9.1%)
Jun 2002
-
$3.76 M(+8.2%)
Mar 2002
-
$3.47 M(-39.7%)
Dec 2001
$5.76 M(+134.0%)
$5.76 M(+128.7%)
Sep 2001
-
$2.52 M(-13.5%)
Jun 2001
-
$2.91 M(+11.2%)
Mar 2001
-
$2.62 M(+6.4%)
Dec 2000
$2.46 M(+36.8%)
$2.46 M(-17.2%)
Sep 2000
-
$2.98 M(+88.4%)
Jun 2000
-
$1.58 M(-28.2%)
Mar 2000
-
$2.20 M(+22.2%)
Dec 1999
$1.80 M(+12.5%)
$1.80 M(+50.0%)
Sep 1999
-
$1.20 M(-25.0%)
Jun 1999
-
$1.60 M(0.0%)
Mar 1999
-
$1.60 M(0.0%)
Dec 1998
$1.60 M(-5.9%)
$1.60 M(+33.3%)
Sep 1998
-
$1.20 M(+9.1%)
Jun 1998
-
$1.10 M(-21.4%)
Mar 1998
-
$1.40 M(-17.6%)
Dec 1997
$1.70 M(-32.0%)
$1.70 M(-29.2%)
Sep 1997
-
$2.40 M(-46.7%)
Jun 1997
-
$4.50 M(-2.2%)
Mar 1997
-
$4.60 M(+84.0%)
Dec 1996
$2.50 M(-66.2%)
$2.50 M(+31.6%)
Sep 1996
-
$1.90 M(-5.0%)
Jun 1996
-
$2.00 M(-16.7%)
Mar 1996
-
$2.40 M(-67.6%)
Dec 1995
$7.40 M
$7.40 M

FAQ

  • What is Titan Pharmaceuticals annual total current liabilities?
  • What is the all time high annual current liabilities for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals annual current liabilities year-on-year change?
  • What is Titan Pharmaceuticals quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Titan Pharmaceuticals?
  • What is Titan Pharmaceuticals quarterly current liabilities year-on-year change?

What is Titan Pharmaceuticals annual total current liabilities?

The current annual current liabilities of TTNP is $1.44 M

What is the all time high annual current liabilities for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high annual total current liabilities is $21.39 M

What is Titan Pharmaceuticals annual current liabilities year-on-year change?

Over the past year, TTNP annual total current liabilities has changed by -$1.19 M (-45.10%)

What is Titan Pharmaceuticals quarterly total current liabilities?

The current quarterly current liabilities of TTNP is $371.00 K

What is the all time high quarterly current liabilities for Titan Pharmaceuticals?

Titan Pharmaceuticals all-time high quarterly total current liabilities is $21.39 M

What is Titan Pharmaceuticals quarterly current liabilities year-on-year change?

Over the past year, TTNP quarterly total current liabilities has changed by -$1.07 M (-74.31%)